Trading CFDs on a leveraged basis involves a significant amount of risk. They may not be suitable for all investors, so please ensure you fully understand all of the risks. Most retail clients lose money when trading CFDs.
Trading CFDs on a leveraged basis involves a significant amount of risk. They may not be suitable for all investors, so please ensure you fully understand all of the risks. Most retail clients lose money when trading CFDs.

US Open: Wall Street indexes open lower at the end of the week 📌

7:01 PM 22 March 2024
  • US500 and US100 slightly lose at the beginning of the session
  • US Dollar (USD) one of the stronger currencies today
  • US bond yields fall to 4.20%

The last day on Wall Street starts in the red. Indexes lose slightly at the opening of the cash session, but it should be noted that the quotations are currently at historical highs. The weaker sentiment in the stock market is also supported by the strengthening dollar. USD gains by 0.3%, and in most currency pairs between 0.3-0.4%, and even up to 0.6% in the case of NZD, AUD, and SEK. Meanwhile, yields on 10-year US bonds lose from the level of 4.21%.

Start investing today or test a free demo

Open real account TRY DEMO Download mobile app Download mobile app

USDIDX index gains over 0.30% and is approaching the key zone around 104,000. This is the second strong session in a row for the dollar, which is starting to exert stronger pressure on the stock market. Source: xStation 5

US500

The US500 index has been moving very dynamically upwards in recent weeks. Along the way, practically since the beginning of 2024, we have not experienced any significant correction. Looking at the chart, one can notice an almost parabolic upward movement. A correction in the indexes would be justified at this moment. However, looking at the market behavior, which finds reasons for growth in each publication, such a correction is hard to predict unequivocally.

Source: xStation 5

Company News

FedEx (FDX.US) gains as much as 8.70% despite mixed results in Fiscal Quarter 3 (FQ3) and a narrowed outlook for Fiscal Year 2024. This surge was attributed to cost-cutting in its Express business and improved margins in FQ3. The Express segment outperformed expectations with a 2.5% operating margin. The company’s overall adjusted operating margin increased to 6.2%. FedEx revised its FY2024 profit guidance to $17.25 - $18.25 per share and announced a new $5 billion share repurchase program.

Ocugen (OCGN.US) gains as much as 17% after a federal appeals court ruling that upheld a lower court's decision against shareholders' claims. These shareholders had accused the biotech company of misleading investors regarding its COVID-19 vaccine, Covaxin, specifically about obtaining emergency-use authorization from the U.S. Food and Drug Administration. The U.S. Court of Appeals for the Third Circuit rejected these claims, stating that the investors couldn't prove any point where Ocugen misrepresented its engagement with the FDA. The court emphasized that all relevant details were accessible to any reasonable investor.

Nike (NKE.US) shares fell by 8% following a revenue outlook that projected minimal growth. Despite exceeding FQ3 earnings expectations, Nike forecasted about 1% growth in FY2024 revenue and a low single-digit decline in the first half of fiscal 2025, mainly due to challenges in overseas markets.

Lululemon Athletica (LULU): dips over 18% after announcing a first-quarter outlook that was below market expectations. The company projected Q1 revenue of $2.18B - $2.20B and EPS of $2.35 - $2.40, both below consensus estimates. The full-year revenue expectation was set at $10.7B - $10.8B, slightly below the consensus.

Reddit (RDDT.US) shares fell by 8% following their debut, which had initially seen a 48% surge. The stock quotations showed strong initial performance, but the decline followed on the subsequent trading day.

Tesla (TSLA.US) shares declined by 3% amid reports of the company reducing electric car production at its China plant due to slowing EV sales growth.

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Share:
Back
Xtb logo

Join over 1 000 000 investors from around the world

We use cookies

By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

This group contains cookies that are necessary for our websites to work. They take part in functionalities like language preferences, traffic distribution or keeping user session. They cannot be disabled.

Cookie name
Description
SERVERID
userBranchSymbol cc 2 March 2024
adobe_unique_id cc 1 March 2025
SESSID cc 2 March 2024
__hssc cc 8 September 2022
__cf_bm cc 8 September 2022
intercom-id-iojaybix cc 26 November 2024
intercom-session-iojaybix cc 8 March 2024

We use tools that let us analyze the usage of our page. Such data lets us improve the user experience of our web service.

Cookie name
Description
_gid cc 9 September 2022
_gat_UA-121192761-1 cc 8 September 2022
_gat_UA-190421227-1 cc 8 September 2022
_ga_CBPL72L2EC cc 1 March 2026
_ga cc 1 March 2026
AnalyticsSyncHistory cc 31 March 2024
__hstc cc 7 March 2023
__hssrc

This group of cookies is used to show you ads of topics that you are interested in. It also lets us monitor our marketing activities, it helps to measure the performance of our ads.

Cookie name
Description
_omappvp cc 11 February 2035
_omappvs cc 1 March 2024
_fbp cc 30 May 2024
fr cc 7 December 2022
muc_ads cc 7 September 2024
lang
_ttp cc 26 March 2025
_tt_enable_cookie cc 26 March 2025
_ttp cc 26 March 2025
hubspotutk cc 7 March 2023

Cookies from this group store your preferences you gave while using the site, so that they will already be here when you visit the page after some time.

Cookie name
Description
personalization_id cc 7 September 2024
UserMatchHistory cc 31 March 2024
bcookie cc 1 March 2025
lidc cc 2 March 2024
lang
bscookie cc 1 March 2025
li_gc cc 28 August 2024

This page uses cookies. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. For more information see our Privacy Policy You can manage cookies by clicking "Settings". If you agree to our use of cookies, click "Accept all".

Change region and language
Country of residence
Language